» Articles » PMID: 26672497

Race and Colorectal Cancer Screening Compliance Among Persons with a Family History of Cancer

Abstract

Aim: To determine compliance to colorectal cancer (CRC) screening guidelines among persons with a family history of any type of cancer and investigate racial differences in screening compliance.

Methods: We used the 2007 Health Information National Trends Survey and identified 1094 (27.4%) respondents (weighted population size = 21959672) without a family history of cancer and 3138 (72.6%) respondents (weighted population size = 58201479) with a family history of cancer who were 50 years and older. We defined compliance with CRC screening as the use of fecal occult blood testing within 1 year, sigmoidoscopy within 5 years, or colonoscopy within 10 years. We compared compliance with CRC screening among those with and without a family member with a history of cancer.

Results: Overall, those with a family member with cancer were more likely to be compliant with CRC screening (64.9% vs 55.1%; OR = 1.45; 95%CI: 1.20-1.74). The absolute increase in screening rates associated with family history of cancer was 8.2% among whites. Hispanics had lowest screening rates among those without family history of cancer 41.9% but had highest absolute increase (14.7%) in CRC screening rate when they have a family member with cancer. Blacks had the lowest absolute increase in CRC screening (5.3%) when a family member has a known history of cancer. However, the noted increase in screening rates among blacks and Hispanics when they have a family member with cancer were not higher than whites without a family history of cancer: (54.5% vs 58.7%; OR = 1.16; 95%CI: 0.72-1.88) for blacks and (56.7% vs 58.7%; OR = 1.25; 95%CI: 0.72-2.18) for Hispanics.

Conclusion: While adults with a family history of any cancer were more likely to be compliant with CRC screening guidelines irrespective of race/ethnicity, blacks and Hispanics with a family history of cancer were less likely to be compliant than whites without a family history. Increased burden from CRC among blacks may be related to poor uptake of screening among high-risk groups.

Citing Articles

Racial/Ethnic Disparities on the Risk of Second Malignant Neoplasm Among Hodgkin Lymphoma Survivors.

Xiao H, He J, Liang S, Cai D, Zhou Q, Liu L Front Oncol. 2022; 11:790891.

PMID: 35141149 PMC: 8818723. DOI: 10.3389/fonc.2021.790891.


Developing genetic counselling services in an underdeveloped healthcare setting.

Ciuca A, Moldovan R, Baban A J Community Genet. 2021; 12(4):539-548.

PMID: 34545547 PMC: 8554932. DOI: 10.1007/s12687-021-00546-z.


Persisting Racial Disparities in Colonoscopy Screening of Persons with a Family History of Colorectal Cancer.

Tsai M, Xirasagar S, de Groen P J Racial Ethn Health Disparities. 2017; 5(4):737-746.

PMID: 28812255 DOI: 10.1007/s40615-017-0418-1.


Using self-reported data on the social determinants of health in primary care to identify cancer screening disparities: opportunities and challenges.

Lofters A, Schuler A, Slater M, Baxter N, Persaud N, Pinto A BMC Fam Pract. 2017; 18(1):31.

PMID: 28241787 PMC: 5330155. DOI: 10.1186/s12875-017-0599-z.

References
1.
Orom H, Kiviniemi M, Underwood 3rd W, Ross L, Shavers V . Perceived cancer risk: why is it lower among nonwhites than whites?. Cancer Epidemiol Biomarkers Prev. 2010; 19(3):746-54. PMC: 2836595. DOI: 10.1158/1055-9965.EPI-09-1085. View

2.
Korner H . Negotiating cultures: disclosure of HIV-positive status among people from minority ethnic communities in Sydney. Cult Health Sex. 2007; 9(2):137-52. DOI: 10.1080/13691050600975462. View

3.
Pinsky P, Kramer B, Reding D, Buys S . Reported family history of cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Am J Epidemiol. 2003; 157(9):792-9. DOI: 10.1093/aje/kwg043. View

4.
Laiyemo A . In search of a perfect solution to ensure that "no colon is left behind". Dig Dis Sci. 2011; 57(2):263-5. DOI: 10.1007/s10620-011-2010-6. View

5.
Singh H, Nugent Z, Demers A, Kliewer E, Mahmud S, Bernstein C . The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer. Gastroenterology. 2010; 139(4):1128-37. DOI: 10.1053/j.gastro.2010.06.052. View